Crossmark

Finerenone in heart failure with ejection fraction ≥40%: state of the art and future perspectives

Crossref DOI link: https://doi.org/10.1016/j.rceng.2026.502520

Published Print: 2026-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Llàcer, Pau

Cobo Marcos, Marta

Nuñez, Julio

Perez Belmonte, Luis M.

Pérez Silvestre, José

Sanchez Marteles, Marta

Comin Colet, José
License Information

Text and Data Mining valid from 2026-03-01

Text and Data Mining valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01

stm-asf valid from 2026-03-01
More Information

This article is maintained by: Elsevier

Article Title: Finerenone in heart failure with ejection fraction ≥40%: state of the art and future perspectives

Journal Title: Revista Clínica Española (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rceng.2026.502520

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rce.2026.502520

Content Type: article

Copyright: © 2026 Published by Elsevier España, S.L.U.